Medicare Enrolled
Dr. Aliakbar Dadla, M.D.
Student in an Organized Health Care Education/Training Program · Vancouver, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dadla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dadla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dadla
Dr. Aliakbar Dadla is a student in an organized health care education/training program specialist in Vancouver, WA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Dadla performed 49,939 Medicare services across 1,337 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dadla received a total of $4,424 from 53 pharmaceutical and/or device companies across 252 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dadla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 0% volume in WA
$4,424 industry payments
Medicare Practice Summary
Medicare Utilization ↗49,939
Medicare services
Top 0% in WA for student in an organized health care education/training program
1,337
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,841 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
20,400 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
13,350 | $0 | $0 |
| Pembrolizumab injection (Keytruda) | 9,600 | $44 | $92 |
| Denosumab injection (Prolia/Xgeva) | 1,380 | $18 | $36 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
996 | $0 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 890 | $1 | $2 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
392 | $2 | $5 |
| Anti-nausea injection (ondansetron/Zofran) | 272 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
258 | $99 | $219 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
240 | $137 | $292 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
212 | $12 | $52 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
212 | $106 | $322 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
151 | $6 | $21 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
123 | $10 | $36 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
123 | $11 | $52 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
110 | $70 | $70 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
106 | $23 | $75 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 103 | $126 | $367 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
97 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
88 | $23 | $75 |
| New patient office visit, complex (60-74 min) | 83 | $165 | $415 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
76 | $51 | $150 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
74 | $26 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
71 | $8 | $13 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
69 | $8 | $16 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
58 | $1 | $1 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
56 | $52 | $160 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
50 | $10 | $22 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $62 | $151 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
41 | $30 | $119 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
39 | $137 | $250 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
35 | $59 | $148 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
32 | $1 | $2 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
27 | $2 | $4 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
26 | $26 | $123 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
21 | $13 | $28 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $133 | $432 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
13 | $21 | $55 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
42.1% high complexity
55.5% medium
2.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,424
Total received (2018-2024)
Avg $632/year across 7 years
Top 6% in WA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
252
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,619 (81.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$804 (18.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,112
2023
$424
2022
$24
2021
$111
2020
$381
2019
$1,521
2018
$850
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$214
Merck Sharp & Dohme LLC
$188
AstraZeneca Pharmaceuticals LP
$139
Daiichi Sankyo Inc.
$90
ABBVIE INC.
$57
E.R. Squibb & Sons, L.L.C.
$43
Janssen Biotech, Inc.
$42
Stemline Therapeutics Inc.
$34
Coherus Biosciences Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
BeiGene USA, Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$28
Regeneron Healthcare Solutions, Inc.
$26
GENZYME CORPORATION
$25
Mirati Therapeutics, Inc.
$22
Genmab U.S., Inc.
$22
Deciphera Pharmaceuticals Inc.
$21
Celgene Corporation
$20
GlaxoSmithKline, LLC.
$16
Incyte Corporation
$16
Eisai Inc.
$13
Top 3 companies account for 48.7% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$434
E.R. Squibb & Sons, L.L.C.
$388
Merck Sharp & Dohme Corporation
$334
Merck Sharp & Dohme LLC
$210
AstraZeneca Pharmaceuticals LP
$207
Novartis Pharmaceuticals Corporation
$206
Amgen Inc.
$179
Janssen Biotech, Inc.
$175
Daiichi Sankyo Inc.
$160
Genentech USA, Inc.
$154
Alexion Pharmaceuticals, Inc.
$150
Astellas Pharma US Inc
$126
Lilly USA, LLC
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
EISAI INC.
$96
Celgene Corporation
$91
Pharmacyclics LLC, An AbbVie Company
$75
Eisai Inc.
$73
Takeda Pharmaceuticals U.S.A., Inc.
$71
Incyte Corporation
$62
GENZYME CORPORATION
$61
Exelixis Inc.
$57
ABBVIE INC.
$57
Regeneron Healthcare Solutions, Inc.
$56
SANOFI-AVENTIS U.S. LLC
$50
Mirati Therapeutics, Inc.
$47
JAZZ PHARMACEUTICALS INC.
$43
Seagen Inc.
$42
Puma Biotechnology, Inc.
$36
Foundation Medicine, Inc.
$36
Janssen Pharmaceuticals, Inc
$35
Stemline Therapeutics Inc.
$34
Coherus Biosciences Inc.
$33
Blueprint Medicines Corporation
$32
BeiGene USA, Inc.
$31
Bayer HealthCare Pharmaceuticals Inc.
$30
Seattle Genetics, Inc.
$29
Dendreon Pharmaceuticals LLC
$28
Gilead Sciences, Inc.
$25
Clovis Oncology, Inc.
$23
Rigel Pharmaceuticals, Inc.
$23
CTI BioPharma Corp.
$22
Genmab U.S., Inc.
$22
Deciphera Pharmaceuticals Inc.
$21
Blue Earth Diagnostics Limited
$18
AbbVie, Inc.
$18
GlaxoSmithKline, LLC.
$16
Grifols USA, LLC
$15
AbbVie Inc.
$14
Kite Pharma, Inc.
$14
Helsinn Therapeutics (U.S.), Inc.
$12
Dova Pharmaceuticals
$12
Kyowa Kirin, Inc.
$12
Top 3 companies account for 26.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AYVAKIT · Alphanate · Aranesp · Avastin · Axumin · BRUKINSA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELITEK · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Enhertu · Epkinly · FOUNDATIONONE · FRUZAQLA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · MEKINIST · MVASI · NINLARO · Nerlynx · Neulasta · Nplate · OFEV · OPDIVO · OPDUALAG · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Perjeta · Pomalyst · QINLOCK · REBLOZYL · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SUTENT · Stivarga · TAGRISSO · TECVAYLI · TUKYSA · Tavalisse · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vanflyta · Venclexta · Vonjo · XALKORI · XARELTO · XTANDI · Yescarta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for student in an organized health care education/training program in WA.
Geographic Context
Student in an organized health care education/training programs within 10 mi
3,222
Per 100K population
631.1
County median income
$94,948
Nearest hospital
PEACEHEALTH SOUTHWEST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dadla is a mixed practice specialist, with above-average Medicare volume (top 0% in WA), with low-engagement industry engagement in the top 6% of WA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dadla experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Dadla performed 20,400 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dadla receive payments from pharmaceutical companies?
Yes. Dr. Dadla received a total of $4,424 from 53 companies across 252 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dadla's costs compare to other student in an organized health care education/training programs in Vancouver?
Dr. Dadla's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dadla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Vancouver
Browse student in an organized health care education/training programs in Vancouver ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in WA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in WA
Which WA student in an organized health care education/training programs receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology